Works by Schelhorn, Sven-Eric

Results: 5
    1

    Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignancies.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-47735-z
    By:
    • Goodstal, Samantha M.;
    • Lin, Jing;
    • Crandall, Timothy;
    • Crowley, Lindsey;
    • Bender, Andrew T.;
    • Pereira, Albertina;
    • Soloviev, Maria;
    • Wesolowski, John S.;
    • Iadevaia, Riham;
    • Schelhorn, Sven-Eric;
    • Ross, Edith;
    • Morandi, Federica;
    • Ma, Jianguo;
    • Clark, Anderson
    Publication type:
    Article
    2
    3

    The DNA60IFX contest.

    Published in:
    Genome Biology, 2013, v. 14, n. 6, p. 1, doi. 10.1186/gb-2013-14-6-124
    By:
    • Schatz, Michael C.;
    • Taylor, James;
    • Schelhorn, Sven-Eric
    Publication type:
    Article
    4
    5